Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 5/20 | 0.44 |
| ▸ | THRB | P10828 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | CASP7 | P55210 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13630709 | 0.87 | MAOA (0.60) | MAOATHRBLMNAPTPN1MAOB | |
| SCHEMBL19398804 | 0.86 | ALOX5 (0.53) | MAOATHRBLMNAMEN1KMT2A | |
| SCHEMBL9779012 | 0.81 | AHR (0.46) | MAOATHRBMEN1KMT2APTPN1 | |
| SCHEMBL1420857 | 0.81 | ALOX5 (0.45) | MAOALMNAMEN1KMT2AALOX5 | |
| SCHEMBL17196520 | 0.81 | ALOX5 (0.42) | MAOATHRBLMNAMEN1KMT2A | |
| SCHEMBL23348910 | 0.80 | KMT2A (0.46) | MAOALMNAMEN1KMT2APTPN1 | |
| SCHEMBL30661436 | 0.80 | ERN1 (0.42) | MAOAPTPN1MAOBALDH1A1TRIM24 | |
| SCHEMBL5319348 | 0.80 | AHR (0.51) | LMNAKMT2ATDP1PTPN1ALDH1A1 | |
| SCHEMBL19774245 | 0.79 | KDM4E (0.45) | MAOATHRBMEN1KMT2APTPN1 | |
| SCHEMBL8536418 | 0.79 | ESR2 (0.41) | MAOATHRBMEN1KMT2APTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119119025-A | Thioketone metal surface corrosion inhibitor material, effect verification method and application | 北京理工大学 | 2024-12-13 | — | — | CN | claimed |
| CN-118994138-A | Preparation method of thioketone metal surface corrosion inhibitor | 北京理工大学 | 2024-11-22 | — | — | CN | claimed |
| CN-118546103-A | 4-Formamide oxazole compound and preparation method and application thereof | 上海大学 | 2024-08-27 | — | — | CN | claimed |
| US-12577263-B2 | Compound and optical film comprising same | LG CHEM, LTD. (KR) | 2026-03-17 | — | — | US | disclosed |
| US-20260040813-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2026-02-05 | — | — | US | disclosed |
| US-12495715-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2025-12-09 | — | — | US | disclosed |
| US-12187748-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2025-01-07 | — | — | US | disclosed |
| CN-119119025-A | Thioketone metal surface corrosion inhibitor material, effect verification method and application | 北京理工大学 | 2024-12-13 | — | — | CN | disclosed |
| CN-118994138-A | Preparation method of thioketone metal surface corrosion inhibitor | 北京理工大学 | 2024-11-22 | — | — | CN | disclosed |
| CN-118546103-A | 4-Formamide oxazole compound and preparation method and application thereof | 上海大学 | 2024-08-27 | — | — | CN | disclosed |
| US-20240254087-A1 | SELECTIVE, PARTIAL, AND ARRESTIN-BIASED 5-HT2A AGONISTS WITH UTILITY IN VARIOUS DISORDERS | NATIONAL INSTITUTES OF HEALTH | 2024-08-01 | — | — | US | disclosed |
| US-20130181190-A1 | NOVEL HETEROLEPTIC IRIDIUM COMPLEXE | UNIVERSAL DISPLAY CORPORATION (US) | 2013-07-18 | — | — | US | disclosed |
| US-20130181190-A1 | NOVEL HETEROLEPTIC IRIDIUM COMPLEXE | UNIVERSAL DISPLAY CORPORATION (US) | 2013-07-18 | — | — | US | disclosed |
| US-20130023541-A1 | VOLTAGE-GATED SODIUM CHANNEL BLOCKERS | GLAXO GROUP LIMITED | 2013-01-24 | — | — | US | disclosed |
| US-20130023541-A1 | VOLTAGE-GATED SODIUM CHANNEL BLOCKERS | GLAXO GROUP LIMITED | 2013-01-24 | — | — | US | disclosed |
| US-20120071487-A1 | PIPERAZINE, PIPERIDINE AND TETRAHYDROPYRIDINE DERIVATIVES AND THEIR PHARMACEUTICAL USE | ATIR HOLDING S.A. | 2012-03-22 | — | — | US | disclosed |
| US-20120043533-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-02-23 | — | — | US | disclosed |
| US-20120043533-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-02-23 | — | — | US | disclosed |
| WO-2010137018-A1 | PIPERAZINE, PIPERIDINE AND TETRAHYDROPYRIDINE DERIVATIVES AND THEIR PHARMACEUTICAL USE | ATIR HOLDING S.A. (LU) | 2010-12-02 | — | — | WO | disclosed |
| US-4344956-A | Oxotetrahydrothiophenes | ERCOLI NICOLO | 1982-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120043533-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING THE SAME | AOC2, AOC3, H1-4 | MAOA 42/4885THRB 2485/4885LMNA 625/4885 |
| US-20130181190-A1 | NOVEL HETEROLEPTIC IRIDIUM COMPLEXE | OCIAD1, OCIAD2, BRD1 | MAOA 1702/4885THRB 4193/4885LMNA 4875/4885 |
| US-12495715-B2 | Organic electroluminescent materials and devices | MCOLN2, MCOLN1, MCOLN3 | MAOA 261/4885THRB 2370/4885LMNA 39/4885 |
| US-20130023541-A1 | VOLTAGE-GATED SODIUM CHANNEL BLOCKERS | KCNB1, KCNB2, SCNN1B | MAOA 1655/4885THRB 1071/4885LMNA 611/4885 |
| US-20260040813-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, MSRB3, GSR | MAOA 1432/4885THRB 1242/4885LMNA 125/4885 |
| US-12187748-B2 | Organic electroluminescent materials and devices | OCIAD1, OCIAD2, TRPA1 | MAOA 596/4885THRB 1722/4885LMNA 2303/4885 |
| US-20120071487-A1 | PIPERAZINE, PIPERIDINE AND TETRAHYDROPYRIDINE DERIVATIVES AND THEIR PHARMACEUTICAL USE | DPYD, BRPF3, BRPF1 | MAOA 2827/4885THRB 2336/4885LMNA 4686/4885 |
| US-12577263-B2 | Compound and optical film comprising same | NR2E3, CBR1, CBR3 | MAOA 208/4885THRB 1917/4885LMNA 3141/4885 |
| US-20240254087-A1 | SELECTIVE, PARTIAL, AND ARRESTIN-BIASED 5-HT2A AGONISTS WITH UTILITY IN VARIOUS DISORDERS | HTR2A, HTR5A, HTR1A | MAOA 188/4885THRB 211/4885LMNA 3342/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.